Int. J. Mol. Sci. 2012, 13(5), 5982-5997; doi:10.3390/ijms13055982
Article

The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma

Al-Madhagi Yaser 1 email, Yan Huang 1 email, Rong-Rong Zhou 1 email, Guan-Sheng Hu 1 email, Mei-Fang Xiao 1 email, Zhe-Bing Huang 1 email, Chao-Jun Duan 2 email, Wei Tian 3 email, Dao-Lin Tang 4 email and Xue-Gong Fan 1,* email
1 Department of Infectious Diseases, Xiangya Hospital, Central South University, Changsha 410008, China 2 Medical Science Institute, Xiangya Hospital, Central South University, Changsha 410008, China 3 Immunogenetics Research Group, Department of Immunology, College of Basic Medical Sciences Central South University, Changsha 410013, China 4 Department of Surgery, Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15219, USA
* Author to whom correspondence should be addressed.
Received: 22 March 2012; in revised form: 9 May 2012 / Accepted: 14 May 2012 / Published: 18 May 2012
PDF Full-text Download PDF Full-Text [284 KB, uploaded 18 May 2012 10:57 CEST]
Abstract: The receptor for advanced glycation end products (RAGE) is oncogenic and overexpressed in human cancers, but its role in hepatocellular carcinoma remains unclear. Here we demonstrated that RAGE is overexpressed in primary hepatocellular carcinoma (PHC) compared to adjacent para-neoplastic liver samples. Serum endogenous secretory RAGE levels were also increased in PHC patients (p < 0.01). Moreover, we demonstrated that RAGE regulates cellular proliferation in Hepatocellular carcinoma (HCC). Knockdown of RAGE by specific siRNA inhibited cellular growth in the hepatocellular carcinoma cell line, Huh7, whereas the RAGE ligand, high mobility group box 1 protein (HMGB1) increased cellular proliferation. In addition, knockdown of RAGE by siRNA arrested cells in the G1 phase and inhibited DNA synthesis (p < 0.01), while HMGB1 protein decreased the number of cells in the G1 phase and increased the number in the S phase (p < 0.05). Furthermore, quantitative real time RT-PCR (qRT-PCR) and Western Blot results demonstrated that RAGE and HMGB1 positively regulate NF-κB p65 expression in Huh7 cells. These studies suggest that RAGE and RAGE ligands are important targets for therapeutic intervention in hepatocellular carcinoma.
Keywords: RAGE; HMGB1; siRNA; NF-κB; proliferation

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Yaser, A.-M.; Huang, Y.; Zhou, R.-R.; Hu, G.-S.; Xiao, M.-F.; Huang, Z.-B.; Duan, C.-J.; Tian, W.; Tang, D.-L.; Fan, X.-G. The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma. Int. J. Mol. Sci. 2012, 13, 5982-5997.

AMA Style

Yaser A-M, Huang Y, Zhou R-R, Hu G-S, Xiao M-F, Huang Z-B, Duan C-J, Tian W, Tang D-L, Fan X-G. The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2012; 13(5):5982-5997.

Chicago/Turabian Style

Yaser, Al-Madhagi; Huang, Yan; Zhou, Rong-Rong; Hu, Guan-Sheng; Xiao, Mei-Fang; Huang, Zhe-Bing; Duan, Chao-Jun; Tian, Wei; Tang, Dao-Lin; Fan, Xue-Gong. 2012. "The Role of Receptor for Advanced Glycation End Products (RAGE) in the Proliferation of Hepatocellular Carcinoma." Int. J. Mol. Sci. 13, no. 5: 5982-5997.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert